Add to ORKGThe invention provides a method of treating a .beta.-lactam-antibiotic-resistant bacterial infection with a combination of a .beta.-lactamanalog (acylaminomethaneboronic acid deriv.). The invention also provides a method of inhibiting a .beta.-lactamase comprising contacting the .beta.-lactamase with a .beta.-lactamanalog. Finally, the invention provides compds. which are .beta.-lactamanalogs and compns. contg. .beta.-lactam analogs
A method of treating a bacterial infection in a subject in need thereof includes administering to th...
The invention relates to heterosubstituted N-thiolated beta-lactams, compositions comprising these c...
With the aim of improving the ability of non-p-lactam inhibitors to inhibit AmpC-beta-tactamase, a s...
The invention provides a method of treating a .beta.-lactam-antibiotic-resistant bacterial infection...
The invention provides novel non-/9-lactam inhibitors of ^-lactamases. In particular, the invention ...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
he invention relates to novel boronic acid compounds, a method for the preparation of such compounds...
Provided herein are heterocyclic compounds and pharmaceutical formulations that can be used to treat...
Compositions and methods are provided for treating or inhibiting a bacterial infection involving at ...
Compositions and methods are provided for treating or inhibiting a bacterial infection involving at ...
Compositions and methods are provided for treating or inhibiting a bacterial infection involving at ...
Compositions and methods are provided for treating or inhibiting a bacterial infection involving at ...
A method of treating a bacterial infection in a subject in need thereof includes administering to th...
The invention relates to heterosubstituted N-thiolated beta-lactams, compositions comprising these c...
With the aim of improving the ability of non-p-lactam inhibitors to inhibit AmpC-beta-tactamase, a s...
The invention provides a method of treating a .beta.-lactam-antibiotic-resistant bacterial infection...
The invention provides novel non-/9-lactam inhibitors of ^-lactamases. In particular, the invention ...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
he invention relates to novel boronic acid compounds, a method for the preparation of such compounds...
Provided herein are heterocyclic compounds and pharmaceutical formulations that can be used to treat...
Compositions and methods are provided for treating or inhibiting a bacterial infection involving at ...
Compositions and methods are provided for treating or inhibiting a bacterial infection involving at ...
Compositions and methods are provided for treating or inhibiting a bacterial infection involving at ...
Compositions and methods are provided for treating or inhibiting a bacterial infection involving at ...
A method of treating a bacterial infection in a subject in need thereof includes administering to th...
The invention relates to heterosubstituted N-thiolated beta-lactams, compositions comprising these c...
With the aim of improving the ability of non-p-lactam inhibitors to inhibit AmpC-beta-tactamase, a s...